I am a former pumper (I hated tubing, although the primary reason I discontinued with pumping was due to insurance issues ... long story on that, but I never suffered at all in terms of glycemic control; my HbA1c is as good now as it ever was on the pump, but pumps to offer the ability to refine dosages better and if your basal needs vary considerably throughout the day, that can be a huge benefit in terms of control). I am considering a return to a pump, provided it has some of the features of the Mendingo Solo. Its a bit thinner, and perhaps the most notable feature for me is that it can be controlled (at least partially) from buttons directly on the pod itself, so if you forget the remote at home (something I've been known to do with my cell phone, my meter, etc.), your dinner out isn't spoiled because you can't bolus for your meal because you can simply press buttons on the Solo pump itself to bolus. I also like the ability to remove it without discarding the entire pod. My understanding is that the next generation Omnipod will also have these features, but so far, Mendingo's Solo will have a significant head start, as Omnipod will still need to attain FDA approval for next generation designs. As for combined functionality, that sounds nice, but CGMS systems still have their flaws, not the least of which is that it is still a struggle to attain insurance coverage for them; the business model of pricing the sensors the way they do is pound-wise and penny-foolish, but in the absence of any reforms to healthcare, they're free to do what the companies want.